Literature DB >> 16848423

NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.

Liming Hou1, Michael G Zagorski.   

Abstract

The Abeta peptide is the major protein component of amyloid deposits in Alzheimer's disease (AD). Age-related microenvironmental changes in the AD brain promote amyloid formation that leads to cell injury and death. Altered levels of metals (such as Cu and Zn) exist in the AD brain, and because Cu and Zn can be bound to the Abeta in the amyloid plaques, it is thought that these binding events in vivo may trigger or prevent Abeta amyloid formation in the AD brain. Although several structural models have been proposed, all of these are undefined due to the lack of definitive structural data. The present NMR studies utilized uniformly 15N-labeled Abeta(1-40) peptide and 1H-15N HSQC experiments and demonstrate for the first time that the Abeta binds Cu and Zn in a distinct manner. The binding promotes NH signal disappearance of E3-V18, which was not due to the paramagnetic effect of Cu2+, as identical NMR studies were seen with Zn2+, which is diamagnetic. NMR titration experiments showed that the amide NH peak intensities of R5-L17 showed the most pronounced intensity reduction, and that the 1H signals for the side chain aromatic signals of the three histidines shift upfield (H6, H13, and H14). We propose that initially Cu2+ is anchored to the Abeta monomer (fast exchange rate) and is followed by deprotonation and/or severe line broadening of the backbone amide NH for E3-V18 (intermediate exchange rate). By contrast, Cu2+ binding to soluble Abeta aggregates leads to rapid aggregation and nonfibrillar amorphous structures, and without metal, the Abeta can undergo the normal time-dependent aggregation, eventually producing more ordered, late-stage parallel beta-sheet structures. These anomalous (rare) binding events may account for some of the unique properties associated with the Abeta, such as its proposed "dual role", where sequestration of metal ions by the monomer is neuroprotective, while that by beta-aggregates generates oxygen radicals and causes neuronal death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16848423     DOI: 10.1021/ja046032u

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  33 in total

1.  Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-β species.

Authors:  Joseph J Braymer; Jung-Suk Choi; Alaina S DeToma; Chen Wang; Kisoo Nam; Jeffrey W Kampf; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Inorg Chem       Date:  2011-09-28       Impact factor: 5.165

Review 2.  Misfolded proteins in Alzheimer's disease and type II diabetes.

Authors:  Alaina S DeToma; Samer Salamekh; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Chem Soc Rev       Date:  2011-08-04       Impact factor: 54.564

Review 3.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

Review 4.  β-Amyloid aggregation and heterogeneous nucleation.

Authors:  Atul K Srivastava; Jay M Pittman; Jonathan Zerweck; Bharat S Venkata; Patrick C Moore; Joseph R Sachleben; Stephen C Meredith
Journal:  Protein Sci       Date:  2019-08-06       Impact factor: 6.725

5.  Aggregation pathways of the amyloid β(1-42) peptide depend on its colloidal stability and ordered β-sheet stacking.

Authors:  Dianlu Jiang; Iris Rauda; Shubo Han; Shu Chen; Feimeng Zhou
Journal:  Langmuir       Date:  2012-08-22       Impact factor: 3.882

6.  Enzyme-linked immunosorbent assay-based method to quantify the association of small molecules with aggregated amyloid peptides.

Authors:  Christina C Capule; Jerry Yang
Journal:  Anal Chem       Date:  2012-01-25       Impact factor: 6.986

7.  Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer's β by solid-state NMR spectroscopy.

Authors:  Sudhakar Parthasarathy; Fei Long; Yifat Miller; Yiling Xiao; Dan McElheny; Kent Thurber; Buyong Ma; Ruth Nussinov; Yoshitaka Ishii
Journal:  J Am Chem Soc       Date:  2011-02-22       Impact factor: 15.419

8.  Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.

Authors:  Sudhakar Parthasarathy; Brian Yoo; Dan McElheny; William Tay; Yoshitaka Ishii
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

Review 9.  Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Chem Rev       Date:  2010-08-11       Impact factor: 60.622

10.  Importance of dynamical processes in the coordination chemistry and redox conversion of copper amyloid-beta complexes.

Authors:  Christelle Hureau; Véronique Balland; Yannick Coppel; Pier Lorenzo Solari; Emiliano Fonda; Peter Faller
Journal:  J Biol Inorg Chem       Date:  2009-07-18       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.